|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.95 USD | +0.85% |
|
-0.07% | -16.67% |
| 25/04 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
| 25/04 | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
BioNTech Reiterates revenue guidance for the full year 2022. The company estimated BioNTech COVID-19 vaccine revenues for the full 2022 financial year of €13 billion - €17 billion.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.67% | 21.02B | |
| -2.63% | 103B | |
| +1.62% | 95.28B | |
| +1.46% | 22.15B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.21% | 16.05B | |
| +5.41% | 13.68B | |
| +33.57% | 12.17B | |
| -24.98% | 8.24B |
BIONTECH SE 
